-+ 0.00%
-+ 0.00%
-+ 0.00%

VISARA SECURES EXCLUSIVE OPTION FOR POTENTIAL ACQUISITION OF YOL104-2 FOR OCULAR SURFACE SQUAMOUS NEOPLASIA

Reuters·10/20/2026 11:03:12